MOTION+
Recovery & Mobility Support
Glow
Multi-peptide Complex · 15 mg · 1 mL
This page provides general product information and handling guidance for MOTION+ Glow. Reconstitution and use should be performed only under the direction of a qualified healthcare professional, in accordance with the applicable professional protocol and local regulations.
sobre o produto
MOTION+ Glow is a lyophilized multi-peptide complex combining Copper Tripeptide-1, TB-500 and BPC-157 in a stated total content of 15 mg, supplied with 1 mL of diluent.
The formulation brings together peptide ingredients researched in connection with cellular signaling, tissue remodeling and biological recovery processes. Evidence and regulatory status differ among its individual components.
Within the ORCHESTRA portfolio, MOTION+ Glow is positioned for professional protocols focused on tissue support, recovery and mobility.
O que está incluído
- One vial of lyophilized MOTION+ Glow Multi-Peptide Complex - 15 mg total.
- One vial of supplied diluent - 1 mL.
- One dropper, supplied separately.
visão geral do produto
- Product Name: MOTION+ Glow.
- ORCHESTRA Line: MOTION+.
- Product Type: Lyophilized Multi-Peptide Complex.
- Active Components: Copper Tripeptide-1, TB-500 and BPC-157.
- Total Lyophilized Content: 15 mg.
- Individual Component Amounts: Not specified.
- Format: Lyophilized Component with Supplied Diluent.
- Supplied Diluent Volume: 1 mL.
- Nominal Final Volume After Reconstitution: 1 mL.
- Nominal Total Concentration: 15 mg/mL.
- Intended Setting: Professional Use.
Ingredientes
- Lyophilized Component: Copper Tripeptide-1, TB-500 and BPC-157 - 15 mg total.
- Individual Component Amounts: Not specified.
- Diluent: Water, Glycerin, 1,2-Propanediol, Phenoxyethanol and Caprylyl Glycol.
Storage Before Reconstitution
- Store at controlled room temperature.
- Do not freeze.
- Protect from light.
- Keep both vials sealed in their original packaging until use.
- Avoid excessive heat and temperature fluctuations.
- Keep out of reach of children.
Reconstitution Information
- Reconstitution must be performed by a qualified healthcare professional using aseptic technique and appropriate sterile transfer equipment suitable for sealed vials.
- Use only the supplied 1 mL diluent.
- Prepare a clean and sanitized work surface before handling the product.
- Inspect the lyophilized vial and supplied diluent vial before use.
- Do not use either vial if its protective seal is broken or damaged, or if its contents appear compromised.
- Remove the protective caps to expose the vial stoppers without removing or damaging the aluminum seals.
- Clean both vial stoppers with a sterile alcohol swab and allow them to air-dry completely.
- Using a new sterile syringe and sterile transfer needle, withdraw the complete 1 mL volume of supplied diluent.
- Slowly transfer the supplied diluent into the lyophilized vial.
- Direct the diluent gently against the inner wall of the vial where possible to minimize foaming and unnecessary agitation.
- Remove the syringe and needle after the complete diluent volume has been transferred.
- Dispose of the used syringe and needle in an approved sharps container.
- Gently swirl or roll the vial until the lyophilized component is fully dissolved.
- Do not shake the vial vigorously.
- Allow the solution to settle and inspect it carefully before use.
- Do not use the reconstituted product if visible contamination, abnormal discoloration, persistent cloudiness or unexpected particles are observed.
- After reconstitution, the nominal final volume is 1 mL.
- After reconstitution, the nominal total concentration is 15 mg/mL.
- The appropriate route of use, quantity, frequency and application method must be determined by the qualified healthcare professional responsible for the protocol.
- The supplied dropper should be used only when appropriate to the selected professional protocol.
Storage After Reconstitution
- Post-reconstitution handling, storage conditions and the maximum in-use period must be determined by the qualified healthcare professional responsible for the protocol.
- Use the reconstituted product promptly whenever possible.
- If the complete volume is not used immediately, retain or reuse the remaining product only under storage conditions established for the applicable professional protocol.
- Keep the reconstituted product securely closed and protected from light.
- Do not freeze.
- Avoid unnecessary or prolonged exposure to heat.
- Do not use if the solution develops abnormal discoloration, persistent cloudiness, visible contamination or unexpected particles.
- Discard any remaining product when directed by the qualified healthcare professional responsible for the protocol.
avisos
- For professional use only.
- Reconstitution and use must be performed under the direction of a qualified healthcare professional.
- The route of administration or application, quantity, frequency and duration of use must be determined by the qualified healthcare professional responsible for the protocol.
- BPC-157 and TB-500 are investigational peptides, and their regulatory status and permitted uses may vary by jurisdiction.
- Competitive athletes must consult the anti-doping regulations applicable to them before use.
- This page provides general product information and does not represent regulatory approval or replace product-specific professional guidance.
- Use only the supplied diluent.
- Do not use if the packaging, vial or protective seal is broken or damaged.
- Do not use if the product appears contaminated or otherwise compromised.
- Do not use after the expiration date shown on the packaging.
- Do not use if an unexpected change in appearance is observed after reconstitution.
- Do not freeze.
- Keep out of reach of children.
Fabricação e Origem
- Manufacturer: ProStemEx, LLC.
- Country of Manufacture: United States.
- Brand: ORCHESTRA.
Lote e Validade
- Lot Number: See packaging.
- Expiration Date: See packaging.
Documentação
- For additional product documentation, batch-specific information or available quality and compliance documentation, contact ORCHESTRA.